Quercetin
Idiopathic Pulmonary Fibrosis · Senolytics
Clinical trials
3
Mechanism
Senolytics
Developer
Mayo Clinic
Overview
Quercetin is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis, acting via senolytics. It appears in 3 tracked IPF clinical trials.
Quercetin clinical trials
Explore related
Medical disclaimer. This page summarizes research about Quercetin for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.